XtIFN genes Frog IFN sequences, together with homologs from zebrafish (DrIFNs), chicken (GgIFNs), and humans (HsIFNs) were aligned using a MUSCLE program through the EMBL-EBI port (http://www.ebi.ac.uk/), and visualized with a Jalview program. The conserved residues, in particular, four cysteine residues were highlighted. (C) Multiple sequence alignment of type I IFNs peptides (both intron-containing, XtIFNs, and intronless, XtIFNXs) in X. tropicalis. Frog IFN sequences, together with homologs from zebrafish (DrIFNs), chicken (GgIFNs), and humans (HsIFNs) were aligned using a MUSCLE program through the EMBL-EBI port (http://www.ebi.ac.uk/), and visualized with a Jalview program. The conserved residues, in particular, four cysteine residues were highlighted. (D) Multiple sequence alignment of type III IFNs peptides (both intron-containing, XtIFNLs, and intronless, XtIFNLXs) in X. tropicalis. Frog IFN sequences, together with homologs from chicken (GgIFNL), and humans (HsIFNLs) were aligned using a MUSCLE program through the EMBL-EBI port (http://www.ebi.ac.uk/), and visualized with a Jalview program. The conserved residues, in particular, four cysteine residues were highlighted. 
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Figure S4. Schematic to categorize IFN genes based on regulatory elements predicted in their proximal promoter regions. The regulatory elements (and pertinent binding factors) in the ~1 kb proximal promoter regions was examined against both human/animal TFD Database using program Nsite (Version 5.2013, at http://www.softberry.com). Showings here include IFNs in X. tropicalis whose promoters containing at least one IFN-or virus-stimulated response elements (ISRE, PRDI, and/or STAT1/3 factors). The other groups of IFN genes, whose promoters do not contain these regulatory elements, and inclusive spread sheet of all predicted regulatory elements and relevant binding factors are listed in the Supplemental Excel Sheet xx. Legend: ○, containing such as GATA-1 regulating constitutive expression; ◊, containing IFN-stimulated response element (ISRE) and PRDI to interact with IRF, ISGF3 and STAT factors; □, containing cis-elements interacting with factors to mediate immune/inflammatory responses including C/EBP, NF-kB, NF-IL6, and p53; •, containing cis-elements reacting with other factors significant in other developmental/physiological responses.
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XtIFNL1 XtIFNL4 Figure S7 . Typical influenza viruses (IAV) subtypes from swine have higher infectivity than those from humans and other animal species in the frog kidney cells. (A) Six IAV subtypes from swine, human, avian, and equine, were used to infect frog A6 cells at different doses (5, 10, and 20 MOI) and the virus infectivity was quantified by cytopathic effect (CPE) using a crystal violet staining procedure. All three tested swine IAV strains showed higher infectivity than the isolates from humans and other animal species; in particular, the TX98 swine IAV seems well adapted to the frog cells causing significant infections at various testing conditions. (B-G) Photomicrographs of frog A6 cells infected by IAV from different animal species to show the significant infections by the swine TX98 and vH1N2 viruses at 3 MOI. The brown spots (arrowheads) in the images are immunohistochemical labeling of IAV using a mAb against influenza nucleoprotein (NP) (H16-L10-4R5, ATCC, HB-65™). The data and micrographs represent results of four independent tests with similar observation.
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Listeria
Relative protection against Listeria (%)   IFN4  IFN6  IFN7  IFNX2  IFNX4  IFNX5  IFNX12  IFNX14  IFNX18  IFNX7  IFNX15  IFNLX1  IFNLX2  IFNL3  IFNL4 monocytogenes (ATCC 19115, at 1.25 X 10 6 /ml) for 1 h, washed and overlaid with the medium containing 0.7% agarose and gentamicin (10 µg/ml) for 24 h. The protection of IFNs from the bacterial infections was then quantified at one day post infection using a neutral red staining procedure. The data and micrographs represent results of four independent tests with similar observation.
